Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott, Robert Weber, Jeffrey A. Sosman, John B.A.G. Haanen, René González, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J.M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia Vaübel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Célèste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael Yellin, Geoffrey Nichol, Axel Hoos, Walter J. Urba

New England Journal of Medicine, 2010

Harvard University, Dana-Farber Cancer Institute, Angeles Clinic and Research Institute, Hadassah Medical Center, Vanderbilt University Medical Center, The Netherlands Cancer Institute, University of Colorado Denver, University of Colorado Cancer Center, Institut Gustave Roussy, Essen University Hospital, German Cancer Research Center, University of Mannheim, Heidelberg University, Huntsman Cancer Institute, Amsterdam UMC Location VUmc, University Hospital and Clinics, University Medical Center, Sylvester Comprehensive Cancer Center, The Christie Hospital, Washington University in St. Louis, Princess Margaret Hospital, Hampton University, Saint Louis University Hospital, Loyola University Medical Center, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Bristol-Myers Squibb (United States), Providence Portland Medical Center

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

15062

Citations

View on Google Scholar

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Abstract

Journal Details

Join JournalsHub

Welcome Back